Market Place
Sourcing Support
Oncorena`s first patient treated with ONC175 in clinical phase I/II trial
04 Sep 2023 //
PR NEWSWIRE
Oncorena Initiates Phase I-II Clinical Trial with Orellanine
01 Feb 2022 //
BIOSPACE
Oncorena Secures Financing of the Company`s Continued Development of Orellanine
22 Dec 2021 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.